TNF and myeloid sarcoma: In addition, dysregulated productions of TNF, another representative pro-inflammatory cytokine, and soluble TNF receptors type I and type II protein levels in CSF are associated with specific clinical profiles, and are useful to identify at a very early stage in MS patients, which is very useful for the prediction of the MS disease outcome [32].